Xenograft models for aromatase inhibitor studies

This publication has 10 references indexed in Scilit:

• Activation of Mitogen-Activated Protein Kinase in Xenografts and Cells during Prolonged Treatment with Aromatase Inhibitor Letrozole
  Cancer Research, 2005
• The Role of Growth Factor Receptor Pathways in Human Breast Cancer Cells Adapted to Long-term Estrogen Deprivation
  Cancer Research, 2005
• Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model
  JNCI Journal of the National Cancer Institute, 2004
• A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
  New England Journal of Medicine, 2004
• Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways
  The Journal of Steroid Biochemistry and Molecular Biology, 2003
• Activation of the MAPK Pathway Enhances Sensitivity of MCF-7 Breast Cancer Cells to the Mitogenic Effect of Estradiol
  Endocrinology, 2002
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer
  British Journal of Cancer, 2000
• The effect of combining aromatase inhibitors with antiestrogens on tumor growth in a nude mouse model for breast cancer
  Breast Cancer Research and Treatment, 1999
• A Multiple Comparison Procedure for Comparing Several Treatments with a Control
  Journal of the American Statistical Association, 1955